|
FDA Office of Minority Health and Health Equity
December 11, 2020
FDA Statement on Vaccines and Related Biological Products Advisory Committee Meeting
The following is attributed to FDA Commissioner Stephen M. Hahn, M.D., and Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research
Following yesterday’s positive advisory committee meeting outcome regarding the Pfizer-BioNTech COVID-19 vaccine, the U.S. Food and Drug Administration has informed the sponsor that it will rapidly work toward finalization and issuance of an emergency use authorization. The agency has also notified the U.S. Centers for Disease Control and Prevention and Operation Warp Speed, so they can execute their plans for timely vaccine distribution.
Additional Resources:
Visit the FDA OMHHE website and follow us on Twitter at @FDAHealthEquity
"Creating a world where health equity is a reality for all."
www.fda.gov/HealthEquity
|
|
|
|
